StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech, healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | LLY Eli Lilly | $1082.20 | -2.06% | $1.02T | 40.2 | 14.1 | +47.4% | 82.8% | 58 |
| 1 | PFE Pfizer | $25.63 | -2.10% | $146.0B | 19.5 | 2.3 | +1.4% | 74.8% | 68 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $44.07 |
| -3.31% |
| $1.30T |
| 10.7 |
| 4.0 |
| +8.1% |
| 81.8% |
| 64 |
| 3 | TEM Tempus AI | $52.80 | +4.62% | $9.5B | — | 7.0 | +69.8% | 63.4% | 62 |
| 4 | GILD Gilead Sciences | $131.10 | -2.48% | $163.2B | 17.7 | 5.5 | +3.5% | 79.3% | 61 |
| 5 | AMGN Amgen | $329.13 | -2.27% | $178.3B | 22.9 | 4.8 | +9.1% | 74.0% | 52 |
| 6 | MRNA Moderna | $46.06 | -2.39% | $18.3B | — | 8.2 | -30.0% | 35.0% | 50 |
| 7 | REGN Regeneron | $600.66 | -2.30% | $62.7B | 14.2 | 4.2 | +5.9% | 85.7% | 47 |
| 8 | VRTX Vertex Pharma | $438.40 | -2.04% | $113.6B | 26.2 | 9.3 | +10.1% | 86.2% | 47 |
| 9 | BNTX BioNTech | $91.70 | -4.43% | $24.3B | — | 8.2 | -11.8% | 82.2% | 41 |